• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预温热、热敷及pH调节对奥沙利铂所致静脉疼痛的预防作用

Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.

作者信息

Kawazoe Hitoshi, Sumikawa Satomi, Nakauchi Kana, Yakushijin Yoshihiro, Yamamoto Yuji, Watanabe Yuji, Tanaka Akihiro, Araki Hiroaki

机构信息

Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.

Division of Nursing, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.

出版信息

Int J Clin Pharm. 2017 Dec;39(6):1291-1297. doi: 10.1007/s11096-017-0536-1. Epub 2017 Oct 13.

DOI:10.1007/s11096-017-0536-1
PMID:29027645
Abstract

Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m were significantly associated with an increased risk of venous pain during all courses (adjusted odds ratio [OR]: 3.18, 95% confidence interval [CI] 1.35-7.92; P < 0.01; and adjusted OR: 3.37, 95% CI 1.26-9.40; P = 0.02, respectively), whereas comprehensive intervention care were significantly associated with reduced risk of venous pain during all courses (adjusted OR: 0.10, 95% CI 0.02-0.44; P < 0.01). Conclusion Comprehensive intervention care is a clinical treatment option for oxaliplatin-induced peripheral venous pain in patients with colorectal cancer, especially females with obesity.

摘要

背景 外周静脉输注奥沙利铂引起的静脉疼痛在临床上仍未得到解决。

目的 本研究旨在确定综合干预护理对接受奥沙利铂治疗的结直肠癌患者静脉疼痛的疗效。

地点 日本一家三级医院。

方法 自2012年4月起,我们对所有门诊患者采用综合干预护理,包括奥沙利铂溶液预加温、热敷以及联合地塞米松进行pH值调节。我们回顾性分析了2009年12月至2014年6月期间经外周静脉接受奥沙利铂治疗的结直肠癌患者的电子病历。

主要观察指标 本研究的主要终点是根据注射部位反应分级≥2级,在奥沙利铂输注期间给药部位静脉疼痛的发生率。

结果 我们评估了59例患者的271个疗程。26例患者的42个疗程(15.5%)出现静脉疼痛。多因素逻辑回归分析显示,女性和体重指数≥25kg/m在所有疗程中均与静脉疼痛风险增加显著相关(校正比值比[OR]:3.18,95%置信区间[CI]1.35 - 7.92;P<0.01;校正OR:3.37,95%CI 1.26 - 9.40;P = 0.02),而综合干预护理在所有疗程中均与静脉疼痛风险降低显著相关(校正OR:0.10,95%CI 0.02 - 0.44;P<0.01)。

结论 综合干预护理是结直肠癌患者奥沙利铂所致外周静脉疼痛的一种临床治疗选择,尤其是肥胖女性患者。

相似文献

1
Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.预温热、热敷及pH调节对奥沙利铂所致静脉疼痛的预防作用
Int J Clin Pharm. 2017 Dec;39(6):1291-1297. doi: 10.1007/s11096-017-0536-1. Epub 2017 Oct 13.
2
[Risk Factors for Oxaliplatin-Induced Phlebitis and Venous Pain, and Evaluation of the Preventive Effect of Preheating with a Hot Compress for Administration of Oxaliplatin].
Gan To Kagaku Ryoho. 2015 Nov;42(11):1397-400.
3
[Etiology and management of venous pain during intravenous administration of oxaliplatin].
Gan To Kagaku Ryoho. 2011 Mar;38(3):411-4.
4
Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO).通过混合类固醇调整pH值对经外周静脉接受奥沙利铂的结直肠癌患者静脉疼痛的影响:一项多中心随机II期研究(APOLLO)
Cancer Chemother Pharmacol. 2015 Dec;76(6):1209-15. doi: 10.1007/s00280-015-2888-3. Epub 2015 Nov 11.
5
[Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain].奥沙利铂稀释液预热输注联合热敷预防奥沙利铂所致静脉疼痛的试验
Gan To Kagaku Ryoho. 2013 Apr;40(4):537-40.
6
[Investigating the incidence of injection-site reactions associated with administration of oxaliplatin into a peripheral vein and management local adverse reactions].[调查奥沙利铂外周静脉给药相关注射部位反应的发生率及局部不良反应的处理]
Gan To Kagaku Ryoho. 2011 Sep;38(9):1447-52.
7
[Search for Factors Related to Vascular Pain Expression upon Administration of Oxaliplatin into a Peripheral Vein].[外周静脉注射奥沙利铂时血管疼痛表现相关因素的研究]
Gan To Kagaku Ryoho. 2015 Jul;42(7):887-9.
8
Risk factors for oxaliplatin-induced vascular pain in patients with colorectal cancer and comparison of the efficacy of preventive methods.结直肠癌患者奥沙利铂所致血管性疼痛的危险因素及预防方法疗效比较
J Pharm Health Care Sci. 2018 Aug 7;4:18. doi: 10.1186/s40780-018-0117-z. eCollection 2018.
9
Oxaliplatin infusion-related venous pain: prevention by simultaneous intravenous fluids.奥沙利铂输注相关静脉疼痛:通过同时静脉输液预防。
BMJ Support Palliat Care. 2021 Jun;11(2):226-229. doi: 10.1136/bmjspcare-2019-002177. Epub 2020 May 25.
10
Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.外周静脉给药与中心静脉给药奥沙利铂输注后局部反应的比较。
J Oncol Pharm Pract. 2016 Apr;22(2):256-60. doi: 10.1177/1078155215576254. Epub 2015 Mar 10.

引用本文的文献

1
Chinese acupoint therapies in cancer pain management: research advances and future perspectives.中医穴位疗法在癌症疼痛管理中的研究进展与未来展望
Pain Manag. 2025 Jun;15(6):345-358. doi: 10.1080/17581869.2025.2510191. Epub 2025 May 22.
2
Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin.评估接受外周静脉化疗(含或不含奥沙利铂)的结直肠癌患者的血管性疼痛。
Sci Rep. 2019 Feb 12;9(1):1819. doi: 10.1038/s41598-018-37966-w.
3
Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy.

本文引用的文献

1
[Risk Factors for Oxaliplatin-Induced Phlebitis and Venous Pain, and Evaluation of the Preventive Effect of Preheating with a Hot Compress for Administration of Oxaliplatin].
Gan To Kagaku Ryoho. 2015 Nov;42(11):1397-400.
2
Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO).通过混合类固醇调整pH值对经外周静脉接受奥沙利铂的结直肠癌患者静脉疼痛的影响:一项多中心随机II期研究(APOLLO)
Cancer Chemother Pharmacol. 2015 Dec;76(6):1209-15. doi: 10.1007/s00280-015-2888-3. Epub 2015 Nov 11.
3
Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients.通过肘正中静脉进行化疗,不使用可植入式中心静脉通路端口:转移性结直肠癌患者的无端口化疗
金纳米棒与热休克蛋白抑制剂VER-155008胶束联合用于结肠癌温和温度光热治疗。
Acta Pharm Sin B. 2018 Jul;8(4):587-601. doi: 10.1016/j.apsb.2018.05.011. Epub 2018 Jun 5.
Int J Clin Oncol. 2015 Apr;20(2):332-7. doi: 10.1007/s10147-014-0703-5. Epub 2014 May 10.
4
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.亚叶酸钙、氟尿嘧啶、奥沙利铂联合贝伐珠单抗与 S-1 和奥沙利铂联合贝伐珠单抗治疗转移性结直肠癌患者(SOFT):一项开放标签、非劣效性、随机 3 期临床试验。
Lancet Oncol. 2013 Dec;14(13):1278-86. doi: 10.1016/S1470-2045(13)70490-X. Epub 2013 Nov 11.
5
[Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain].奥沙利铂稀释液预热输注联合热敷预防奥沙利铂所致静脉疼痛的试验
Gan To Kagaku Ryoho. 2013 Apr;40(4):537-40.
6
[Etiology and management of venous pain during intravenous administration of oxaliplatin].
Gan To Kagaku Ryoho. 2011 Mar;38(3):411-4.
7
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.卡培他滨联合奥沙利铂对比氟尿嘧啶和亚叶酸钙作为辅助治疗局部晚期结肠癌的疗效。
J Clin Oncol. 2011 Apr 10;29(11):1465-71. doi: 10.1200/JCO.2010.33.6297. Epub 2011 Mar 7.
8
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.贝伐单抗联合奥沙利铂为基础的化疗作为转移性结直肠癌的一线治疗:一项随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.
9
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.卡培他滨联合奥沙利铂与氟尿嘧啶/亚叶酸钙联合奥沙利铂作为转移性结直肠癌一线治疗的随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2006-12. doi: 10.1200/JCO.2007.14.9898.
10
High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.高体重指数与长春瑞滨输注引起静脉刺激的风险增加相关。
Jpn J Clin Oncol. 2004 Apr;34(4):206-9. doi: 10.1093/jjco/hyh029.